News - Exelon Patch

Filter

Current filters:

Exelon Patch

Popular Filters

European Alzheimer's drug market to grow to $4.78 billion by 2019, says F&S

25-11-2012

The patent expiry of all four existing European Medicines Agency-approved drugs for Alzheimer's disease…

AriceptEbixaEisaiEuropeExelon PatchLundbeckMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalResearch

FDA backs higher dose of Novartis Exelon Patch for Alzheimer's

04-09-2012

The US Food and Drug Administration has approved a higher dose of Swiss drug major Novartis' (NOVN: VX)…

Exelon PatchNeurologicalNorth AmericaNovartisPharmaceuticalRegulation

Company Spotlight

Fibrotech

Fibrotech

Back to top